11-2572089-G-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The ENST00000155840.12(KCNQ1):c.760G>T(p.Val254Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V254M) has been classified as Pathogenic.
Frequency
Consequence
ENST00000155840.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.760G>T | p.Val254Leu | missense_variant | 5/16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.760G>T | p.Val254Leu | missense_variant | 5/16 | 1 | NM_000218.3 | ENSP00000155840 | P1 | |
KCNQ1 | ENST00000335475.6 | c.379G>T | p.Val127Leu | missense_variant | 5/16 | 1 | ENSP00000334497 | |||
KCNQ1 | ENST00000496887.7 | c.499G>T | p.Val167Leu | missense_variant | 6/16 | 5 | ENSP00000434560 | |||
KCNQ1 | ENST00000646564.2 | c.478-11346G>T | intron_variant | ENSP00000495806 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2017 | The p.V254L variant (also known as c.760G>T), located in coding exon 5 of the KCNQ1 gene, results from a G to T substitution at nucleotide position 760. The valine at codon 254 is replaced by leucine, an amino acid with highly similar properties, and is located in the S4-S5 linker region. This variant has been reported in individuals with long QT syndrome (LQTS) (Zareba W et al. J. Cardiovasc. Electrophysiol., 2003 Nov;14:1149-53; Napolitano C et al. JAMA, 2005 Dec;294:2975-80). Alternate amino acid substitutions at this position (p.V254M, p.V254A) have also been reported to adversely affect the voltage-gated potassium ion channel in individuals with LQTS (Wang Z et al. J Cardiovasc Electrophysiol. 1999;10(6):817-26; Labro AJ et al. J. Biol. Chem., 2011 Jan;286:717-25). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:14678125;PMID:16414944;PMID:17999538). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at